88 related articles for article (PubMed ID: 1506010)
1. Pathogenesis of wasting disease after cyclophosphamide treatment of neonatal mice.
Bains GS; Dhake GS
Indian J Exp Biol; 1992 Jan; 30(1):1-4. PubMed ID: 1506010
[TBL] [Abstract][Full Text] [Related]
2. Late effects of cyclophosphamide treatment of neonatal mice.
Bains GS; Dhake GS
Indian J Exp Biol; 1992 Mar; 30(3):205-10. PubMed ID: 1512028
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclophosphamide-induced elimination of lymphocytes from the spleen and lymph node on immune response in mice.
Konys J; Mackiewicz U; Drygas J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):783-8. PubMed ID: 7349098
[TBL] [Abstract][Full Text] [Related]
4. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
5. Delayed toxicity of cyclophosphamide in normal mice.
Anton E
Br J Exp Pathol; 1987 Apr; 68(2):237-49. PubMed ID: 3555594
[TBL] [Abstract][Full Text] [Related]
6. Repair processes of hemopoiesis after applying cyclophosphamide. II. Quantitative changes in basic proteins and DNA in the bone marrow, spleen, and thymus.
Süliová J; Macková N; Hvizdosová M; Gábor J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):605-14. PubMed ID: 2435626
[TBL] [Abstract][Full Text] [Related]
7. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
8. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic characteristics of graft-versus-host disease produced in cyclophosphamide-treated adult mice.
Sandberg JS; Owens AH; Santos GW
J Natl Cancer Inst; 1971 Jan; 46(1):151-60. PubMed ID: 4395991
[No Abstract] [Full Text] [Related]
10. [Effect and anti-lymphatic specificity of a combination of cyclophosphamide and vinblastine on normal lymphopoietic tissues in the mouse].
Tognella S; Conigliaro S; Scaltrini GC; Recalcati P; Grifoni V
Haematol Lat; 1970; 13(2):135-44. PubMed ID: 5504039
[No Abstract] [Full Text] [Related]
11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production.
Klimpel GR; Annable CR; Cleveland MG; Jerrells TR; Patterson JC
J Immunol; 1990 Jan; 144(1):84-93. PubMed ID: 2104894
[TBL] [Abstract][Full Text] [Related]
13. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
14. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive effects of cyclophosphamide in pigs.
Mackie EJ
Am J Vet Res; 1981 Feb; 42(2):189-94. PubMed ID: 6973301
[TBL] [Abstract][Full Text] [Related]
16. [Status of nucleoprotein synthesis in hematopoietic organs in mice with primary hypothyroidism].
Kozlov IuA; Shevtsova NM; Pleshko RI; Kurlov OV; Baĭkov AN; Novitskiĭ VV
Vopr Med Khim; 1993; 39(1):56-8. PubMed ID: 8498073
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
18. Reversal of post-thymectomy wasting disease in mice by multiple thymus grafts.
Stutman O; Yunis EJ; Martinez C; Good RA
J Immunol; 1967 Jan; 98(1):79-87. PubMed ID: 6018772
[No Abstract] [Full Text] [Related]
19. Repair processes of hemopoiesis after applying cyclophosphamide. I. Morphological changes in the bone marrow, spleen and thymus.
Macková N; Süliová J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):596-604. PubMed ID: 2435625
[TBL] [Abstract][Full Text] [Related]
20. [Disorders in the formation of the hematologic status of mice following rat lymph node transplantation during the early postnatal period].
Maianskiĭ DN
Ontogenez; 1975; 6(5):492-502. PubMed ID: 1052339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
